Increasing incidence of adenovirus disease in bone marrow transplant recipients

Journal of Infectious Diseases

Volumn 169, Issue 4, 1994, Pages 775-781

  Flomenberg, Phyllis ^a   Babbitt, Jill ^a,b   Drobyski, William R ^a   Ash, Robert C ^a,c   Carrigan, Donald R ^a   Sedmak, Gerald V ^a   Mc Auliffe, Timothy ^a   Camitta, Bruce ^a   Horowitz, Mary M ^a   Bunin, Nancy ^a,d   Casper, James T ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

^c The Methodist Hospital   (United States)

^d Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBODY; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SEROTYPE; VIRUS CULTURE; VIRUS INFECTION; VIRUS NEUTRALIZATION; WHOLE BODY RADIATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; AGE FACTORS; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; INFANT; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; TIME FACTORS;

EID: 0028256278     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.4.775     Document Type: Article

References (32)

1. Horwitz MS. Adenoviruses. In: Fields BN, Knipe DM, Chanock RM, et al, eds. Fields virology. 2nd ed. New York: Raven Press, 1990:1723-40.
2. Shields AF. Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985:312:529-33.
3. Michaels MG, Green M, Wa ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992:165:170-4.
4. Stadler H, Hierholzer JC, Oxman MN. New human adenovirus (candidate adenovirus type 35) causing a fatal disseminated infection in a renal transplant recipient. J Clin Microbiol 1977;6:257-65.
5. Wigger HJ, Blanc WA. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med 1966;275:870-4.
6. South MA, Dolen J, Beach DK, Mirkovic RR. Fatal adenovirus hepatic necrosis in severe combined immune deficiency. Pediatr Infect Dis 1982;1:416-9.
7. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980;68:725-32.
8. Krilov LR, Rubin LG, Frogel M, et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 1990;12:303-7.
9. Myerowitz RL, Stalder H, Oxman MN, et al. Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 1975;59:591-8.
10. Koneru B, Atchison R, Jaffe R, Cassavilla A, Van Thiel DH, Starzl TE. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 1990;22:1547-8.
11. Ash RC, Casper JT, Chitambar CR, et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990;322:485-94.
12. Waid TH, Lucas BA, Amlot P, et al. T10B9.1A-31 anti-T-cell monoclonal antibody: Preclinical studies and clinical treatment of solid organ allograft rejection. Am J Kidney Dis 1989;14:61-70.
13. Graham-Pole J, Casper J, Elfenbein G, etal. High-dosechemoradiother-apy supported by marrow infusions for advanced neuroblastoma: A pediatric oncology group study. J Clin Oncol 1991;5:152-8.
14. Yeager AM, Kaizer H, Santos GW, et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophospha-mide. N Engl J Med 1986;315:141-7.
15. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
16. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: A long term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
17. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987:69:369-80.
18. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153:478-88.
19. Horvath J, Palkonyay L, Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J Virol 1986:59:189-92.
20. Fife KH, Ashley R, Shields AF, Salter D, Meyers J D, Corey L. Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus. J Clin Microbiol 1985;22:95-100.
21. de Jong PJ, Valderrama G, Spigland I, Horwitz MS. Adenovirus isolates from the urine of patients with acquired immunodeficiency syndrome. Lancet 1983;1:1293-6.
22. Flomenberg PR, Chen M, Munk G, Horwitz MS. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts. J Infect Dis 1987; 155:1127-34.
23. Ambinder RF, Burns W, Forman M, et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986;146:1400-1.
24. Wasserman R, August C, Plotkin S. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988;7:109-15.
25. Marks DI, Cullis JO, Ward KN, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Ann Intern Med 1993; 119:207-14.
26. Casper JT, Bunin N, Truitt R, Camitta B, Ash R. Pediatric bone marrow transplantation utilizing unrelated donors. In; Johnson FL, Pochedly C, eds. Bone marrow transplantation in children. New York: Raven Press, 1990:301-25.
27. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
28. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;7:247-8.
29. Taylor DL, Jeffries, DJ, Taylor-Robinson D, Parkin JM, Tyms AS. The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG). FEMS Microbiol Lett 1988;49:337-41.
30. Dagan R, Schwartz RH, Insel RA, Menegus MA. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: Possible therapeutic effect of human serum globulin containing a specific neutralizing antibody. Pediatr Infect Dis 1984;3:246-51.
31. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41.
32. Baba M, Mori S, Shigeta S, De Clerq E. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro. Antimicrob Agents Chemother 1987;31:337-9.